Arteriovenous shunting in patients with colorectal liver metastases. 1991

J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
University Department of Surgery, Royal Infirmary, Glasgow, UK.

The outlook for patients with colorectal liver metastases is poor. Microspheres have been combined with cytotoxics and administered via the hepatic artery in an attempt to improve tumour drug exposure within the liver. However, it has been suggested that arteriovenous connections might occur in association with intrahepatic tumours causing loss of regional advantage, and that the administration of microspheres further exacerbates arteriovenous shunting. In seven patients with colorectal liver metastases, base-line shunting was measured using a tracer quantity of radio-labelled albumin microspheres. The shunted fraction of a 'therapeutic quantity' of microspheres was subsequently measured in the same group of patients using albumin microspheres carrying a different radio-label. Base-line shunt for 0.5 x 10(6) microspheres was found to be 2.2 +/- 1.8% (mean +/- s.d.); the percentage shunt of a therapeutic quantity (40-80 x 10(6)) of microspheres was 3.0 +/- 0.8%. We conclude that arteriovenous shunting in patients with colorectal liver metastases is minimal, and is not significantly increased by the administration of therapeutic quantity of microspheres during regional chemotherapy.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
December 1987, Nuclear medicine communications,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
April 1995, The Journal of pediatrics,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
April 2016, Journal of surgical oncology,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
August 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
January 2022, Digestion,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
April 1990, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
August 2017, The Journal of surgical research,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
October 2015, Surgery today,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
June 1987, The Journal of laboratory and clinical medicine,
J A Goldberg, and J A Thomson, and G McCurrach, and J H Anderson, and N Willmott, and R G Bessent, and J H McKillop, and C S McArdle
July 1977, Gastroenterology,
Copied contents to your clipboard!